Collectively, these studies along with the results from our present findings suggest that a maintained ADAM17 activity, via regulating substrate availability, such as TNFα or TNFRI and TNFRII plays a role in AD pathogenesis. The gene discussed is TNFRSF1A; the disease is Alzheimer disease.